VG-1 is a B cell line which was derived from primary effusion lymphoma (PEL) ( Lu et al. 2009). It was first established in 2000 by David T. Scadden’s group at Massachusetts General Hospital. It is infected with Kaposi's sarcoma-associated herpesvirus (KSHV), but negative with Epstein–Barr virus (EBV) ( Brander et al. 2000).
VG-1 is a B cell line which was derived from primary effusion lymphoma (PEL) ( Lu et al. 2009). It was first established in 2000 by David T. Scadden’s group at Massachusetts General Hospital. It is infected with Kaposi's sarcoma-associated herpesvirus (KSHV), but negative with Epstein–Barr virus (EBV) ( Brander et al. 2000).